Cargando…
Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis
The global tuberculosis (TB) epidemic and the spread of multi- and extensively-drug resistant strains of Mycobacterium tuberculosis (M.tb) have been fueled by low adherence to following lengthy treatment protocols, and the rapid spread of HIV (Human Immunodeficiency Virus). Persistence of the infect...
Autores principales: | Maiga, Mamoudou, Ahidjo, Bintou Ahmadou, Maiga, Mariama C., Cheung, Laurene, Pelly, Shaaretha, Lun, Shichun, Bougoudogo, Flabou, Bishai, William R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563140/ https://www.ncbi.nlm.nih.gov/pubmed/26425693 http://dx.doi.org/10.1016/j.ebiom.2015.07.014 |
Ejemplares similares
-
Erratum to “Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis” [EBioMedicine 2 (8), August 2015, 868–873]
por: Maiga, Mamoudou, et al.
Publicado: (2015) -
Synthetic Lethality Reveals Mechanisms of Mycobacterium tuberculosis Resistance to β-Lactams
por: Lun, Shichun, et al.
Publicado: (2014) -
Phosphodiesterase inhibitors as adjunctive therapies for tuberculosis
por: Ahidjo, Bintou Ahmadou, et al.
Publicado: (2016) -
Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model
por: Maiga, Mamoudou, et al.
Publicado: (2012) -
Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis
por: Bhattacharya, Debapriya, et al.
Publicado: (2014)